Morgan Stanley Raises AMETEK (NYSE:AME) Worth Goal to $152.00

AMETEK (NYSE:AME – Get Score) had its worth goal upped by equities researchers at Morgan Stanley from $144.00 to $152.00 in a analysis notice issued on Friday, Benzinga reviews. The brokerage at present has an “chubby” ranking on the expertise firm’s inventory. Morgan Stanley’s worth goal suggests a possible upside of 10.16% from the inventory’s present worth.

AME has been the topic of a number of different reviews. Mizuho boosted their worth goal on AMETEK from $140.00 to $145.00 and gave the corporate a “purchase” ranking in a report on Wednesday, November 2nd. Royal Financial institution of Canada raised their worth goal on AMETEK from $135.00 to $136.00 and gave the inventory an “outperform” ranking in a analysis notice on Wednesday, November 2nd. KeyCorp raised their worth goal on AMETEK from $145.00 to $165.00 and gave the inventory an “chubby” ranking in a analysis notice on Monday, November twenty first. StockNews.com lowered AMETEK from a “purchase” ranking to a “maintain” ranking in a analysis notice on Thursday. Lastly, Wells Fargo & Firm decreased their worth goal on AMETEK from $180.00 to $165.00 and set an “chubby” ranking on the inventory in a analysis notice on Monday, October twenty fourth. Three equities analysis analysts have rated the inventory with a maintain ranking and 6 have assigned a purchase ranking to the corporate’s inventory. Based mostly on information from MarketBeat.com, the corporate at present has a consensus ranking of “Reasonable Purchase” and a consensus worth goal of $148.89.

AMETEK Buying and selling Down 2.0 %

Shares of AMETEK inventory opened at $137.98 on Friday. AMETEK has a 1 12 months low of $106.17 and a 1 12 months excessive of $146.02. The corporate has a debt-to-equity ratio of 0.29, a present ratio of 1.53 and a fast ratio of 0.88. The enterprise has a 50 day transferring common worth of $138.82 and a 200 day transferring common worth of $125.56. The corporate has a market capitalization of $31.69 billion, a P/E ratio of 28.22, a P/E/G ratio of two.52 and a beta of 1.22.

AMETEK (NYSE:AME – Get Score) final posted its quarterly earnings information on Tuesday, November 1st. The expertise firm reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.08. AMETEK had a return on fairness of 18.40% and a internet margin of 18.81%. The enterprise had income of $1.55 billion for the quarter, in comparison with analyst estimates of $1.51 billion. Throughout the identical quarter final 12 months, the corporate earned $1.26 earnings per share. The enterprise’s income for the quarter was up 7.7% in comparison with the identical quarter final 12 months. Promote-side analysts anticipate that AMETEK will put up 5.63 EPS for the present fiscal 12 months.

Insiders Place Their Bets

In different AMETEK information, insider Thomas C. Marecic offered 10,000 shares of AMETEK inventory in a transaction that occurred on Wednesday, November twenty third. The inventory was offered at a mean worth of $142.05, for a complete transaction of $1,420,500.00. Following the sale, the insider now immediately owns 31,622 shares within the firm, valued at roughly $4,491,905.10. The transaction was disclosed in a doc filed with the Securities & Alternate Fee, which is offered via the SEC web site. In different information, insider Thomas C. Marecic offered 2,318 shares of the enterprise’s inventory in a transaction that occurred on Monday, November twenty first. The inventory was offered at a mean worth of $141.01, for a complete worth of $326,861.18. Following the completion of the sale, the insider now immediately owns 31,622 shares within the firm, valued at roughly $4,459,018.22. The sale was disclosed in a doc filed with the Securities & Alternate Fee, which is offered via this hyperlink. Additionally, insider Thomas C. Marecic offered 10,000 shares of the enterprise’s inventory in a transaction that occurred on Wednesday, November twenty third. The shares have been offered at a mean worth of $142.05, for a complete worth of $1,420,500.00. Following the completion of the sale, the insider now owns 31,622 shares of the corporate’s inventory, valued at $4,491,905.10. The disclosure for this sale may be discovered right here. Insiders have offered 15,038 shares of firm inventory value $2,129,848 within the final three months. 0.72% of the inventory is owned by insiders.

Institutional Traders Weigh In On AMETEK

Quite a few institutional buyers have lately made modifications to their positions in AME. CCLA Funding Administration purchased a brand new stake in shares of AMETEK within the third quarter valued at roughly $69,179,000. Renaissance Applied sciences LLC boosted its place in AMETEK by 127.5% through the 2nd quarter. Renaissance Applied sciences LLC now owns 994,518 shares of the expertise firm’s inventory valued at $109,288,000 after buying a further 557,368 shares through the interval. Goldman Sachs Group Inc. boosted its place in AMETEK by 45.6% through the 1st quarter. Goldman Sachs Group Inc. now owns 1,549,101 shares of the expertise firm’s inventory valued at $206,310,000 after buying a further 485,407 shares through the interval. Vanguard Group Inc. boosted its place in AMETEK by 1.9% through the 1st quarter. Vanguard Group Inc. now owns 24,608,566 shares of the expertise firm’s inventory valued at $3,277,369,000 after buying a further 463,926 shares through the interval. Lastly, Ceredex Worth Advisors LLC acquired a brand new place in AMETEK through the third quarter valued at roughly $45,931,000. 85.42% of the inventory is at present owned by institutional buyers.

About AMETEK

(Get Score)

AMETEK, Inc manufactures and sells digital devices and electromechanical units worldwide. It operates in two segments, Digital Devices (EIG) and Electromechanical (EMG). The corporate’s EIG section presents superior devices for the method, aerospace, energy, and industrial markets; course of and analytical devices for the oil and fuel, petrochemical, pharmaceutical, semiconductor, automation, and meals and beverage industries; and devices to the laboratory gear, ultra-precision manufacturing, medical, and take a look at and measurement markets.

Learn Extra

Analyst Recommendations for AMETEK (NYSE:AME)

This instantaneous information alert was generated by narrative science expertise and monetary information from MarketBeat in an effort to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial crew previous to publication. Please ship any questions or feedback about this story to [email protected]

Earlier than you think about AMETEK, you may wish to hear this.

MarketBeat retains observe of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they advocate to their shoppers each day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and AMETEK wasn’t on the record.

Whereas AMETEK at present has a “Reasonable Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.

View The 5 Shares Right here

10

Leave a Reply